Source: BioPortfolio

Amniox Medical: AMNIOX Medical Introduces RESPINA at NASS 2017

RESPINA umbilical cordamniotic membrane matrix for microdiscectomy earns 2017 Spine Technology Award AMNIOX Medical Inc. a TissueTech Inc. company highlighted the introduction of RESPINA its cryopreserved umbilical cordam...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Amy Tseng's photo - President & CEO of Amniox Medical

President & CEO

Amy Tseng

CEO Approval Rating

86/100

Read more